Bisphosphonates don’t cut risk of breast cancer

Three to four years of therapy with the bisphosphonates alendronate and zoledronic acid, taken at doses used to treat osteoporosis, did not decrease the risk of incident breast cancer in...

Field of Interest: Oncology
Type: News Item

Bisphosphonates don’t cut risk of breast cancer

Three to four years of therapy with the bisphosphonates alendronate and zoledronic acid, taken at doses used to treat osteoporosis, did not decrease the risk of incident breast cancer in...

Field of Interest: Pulmonology
Type: News Item

Combined hormonal contraception raises VTE risk fivefold

Combined hormonal contraception raises the risk for venous thromboembolism fivefold overall, with certain formulations increasing that risk even further and with thrombophilic genotypes raising it...

Field of Interest: Pulmonology
Type: News Item

Recent use of oral contraceptives linked to breast cancer

Women who recently used oral contraceptives had a 50% greater chance of developing breast cancer than that of women who formerly used or never used oral contraceptives, according to a case-control...

Field of Interest: Oncology
Type: News Item

Hormonal birth control linked to gestational diabetes

Missouri women who used hormonal birth control were 1.4 times more likely to develop gestational diabetes, compared with those who used no birth control, according to a first-in-kind study published...

Field of Interest: Pulmonology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness